New Delhi, April 13 (IANS) India is poised to lead the global pharmaceutical landscape due to its focus on biologics, biosimilars and specialty medicines, Health Minister JP Nadda said on Monday.The minister highlighted that the government recently launched Biopharma Shakti Initiative with an outlay of Rs 10,000 crore, to advance capabilities in biopharmaceutical innovation, foster innovation and strengthen research capabilities. Union Minister of State for Health and Family Welfare, Anupriya Pa…
Latest Indian Pharmaceutical Alliance News & Updates
New Delhi, Feb 7 (IANS) Health industry leaders on Saturday welcomed the interim agreement on the bilateral trade deal between India and the US.As part of the interim framework, the US will slash reciprocal tariffs on Indian goods to 18 per cent. The US will also remove the reciprocal tariff on generic pharmaceuticals, among other sectors like gems and diamonds, and aircraft parts. Although full details are yet to emerge, the interim India-US trade deal framework indicates that India has receive…
New Delhi, Feb 1 (IANS) Industry experts on Sunday hailed the Union Budget 2026’s push to the biopharma sector, clinical trials, along with its thrust to the medical tourism and Ayurveda.The Union Budget 2026-27, presented by Finance Minister Nirmala Sitharaman in Parliament, proposed the Biopharma Shakti (Strategy for Healthcare Advancement through Knowledge, Technology, and Innovation) scheme.The scheme, with an outlay of Rs 10,000 crores over the next five years, aims to develop India as a …
New Delhi, Jan 19 (IANS) The healthcare industry leaders and experts on Monday urged the government to significantly scale up public spending on healthcare in the forthcoming Union Budget 2026-27.The Association of Healthcare Providers – India (AHPI) noted that public health expenditure continues to remain well below the National Health Policy target of 2.5 per cent of GDP, and lags behind benchmarks seen in comparable developing economies.AHPI highlighted that India’s healthcare system is fac…
Gandhinagar, Dec 30 (IANS) In a move to strengthen India’s artificial intelligence (AI) ecosystem, Gujarat will operationalise the Indian AI Research Organisation (IAIRO) from January 1, 2026, under a Public-Private Partnership (PPP) model. Chief Minister Bhupendra Patel has granted in-principle approval for the initiative, making Gujarat the first state in the country to establish such an institution through a PPP framework.Aligned with the vision of Prime Minister Narendra Modi and under the…
New Delhi, Dec 25 (IANS)With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday, while highlighting innovation and increased access as key factors for the sector’s growth in 2026.Indian pharma is standing at a defining moment. In the past 25 years, the industry has grown from $3 billion to $60 billion. The next 25 years will be shaped by innovation, quality, and access.“The year 2025…